Skip to main content
Premium Trial:

Request an Annual Quote

MissyToo Isn't Quite Like Missy

Bioarts' chairman Lou Hawthorne talks to the New York Times' Home and Garden section about two dogs that were cloned for him from a border collie-husky mix that died in 2002. The two dogs are not identical to Missy and some of that variation is chalked up to the dogs having mitochondrial DNA from another dog and the egg being implanted in yet another dog. Hawthorne says these clones are the first commercially cloned dogs, however the Korean company RNL Bio has made the same claim. Bioarts and RNL are currently involved in a lawsuit over patent rights.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.